Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ARIPIPRAZOLE Cause Extra dose administered? 23 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Extra dose administered have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 0.0% of all adverse event reports for ARIPIPRAZOLE.

23
Reports of Extra dose administered with ARIPIPRAZOLE
0.0%
of all ARIPIPRAZOLE reports
1
Deaths
8
Hospitalizations

How Dangerous Is Extra dose administered From ARIPIPRAZOLE?

Of the 23 reports, 1 (4.3%) resulted in death, 8 (34.8%) required hospitalization, and 1 (4.3%) were considered life-threatening.

Is Extra dose administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE. However, 23 reports have been filed with the FAERS database.

What Other Side Effects Does ARIPIPRAZOLE Cause?

Drug ineffective (5,566) Off label use (5,473) Product use in unapproved indication (4,792) Weight increased (4,636) Anxiety (3,076) Suicide attempt (2,796) Suicidal ideation (2,618) Condition aggravated (2,157) Insomnia (2,147) Akathisia (2,107)

What Other Drugs Cause Extra dose administered?

TIRZEPATIDE (6,774) DULAGLUTIDE (3,047) LORATADINE (1,556) DUPILUMAB (1,422) FEXOFENADINE (1,413) NAPROXEN (908) POLYETHYLENE GLYCOL 3350 (589) ACETAMINOPHEN (552) DALFAMPRIDINE (519) FLUTICASONE\SALMETEROL (499)

Which ARIPIPRAZOLE Alternatives Have Lower Extra dose administered Risk?

ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL ARIPIPRAZOLE vs ARIXTRA ARIPIPRAZOLE vs ARMODAFINIL ARIPIPRAZOLE vs AROMASIN ARIPIPRAZOLE vs ARSENIC TRIOXIDE

Related Pages

ARIPIPRAZOLE Full Profile All Extra dose administered Reports All Drugs Causing Extra dose administered ARIPIPRAZOLE Demographics